Boirie. Protein synthesis rates of human PBMC and PMN can be determined simultaneously in vivo by using small blood samples. Am J Physiol Cell Physiol 286: C1474 -C1478, 2004. First published January 28, 2004 10.1152/ajpcell.00563.2002.-Immune cell functions can be evaluated in vivo by measuring their specific protein fractional synthesis rates (FSR). Using stable isotope dilution techniques, we describe a new method allowing simultaneous in vivo assessment of FSR in two leukocyte populations in healthy human subjects, using small blood samples. Peripheral blood mononuclear cell (PBMC) and polymorphonuclear neutrophil (PMN) FSR were measured during primed continuous intravenous infusion of L-[1-13 C]leucine. Immune cells from 6 ml of whole blood were isolated by density gradient centrifugation. In a first study, we calculated the FSR using plasma [ 13 C]leucine or ␣-[ 13 C]ketoisocaproate (KIC) enrichments as precursor pools. In a second study, we compared protein FSR in leukocytes, using enrichments of either intracellular or plasma free [
nutrition (11, 16, 20) . A decline in immune functions is also reported during aging (for review, see Ref. 30) . Moreover, nutritional status in animals or humans is an important determinant of immunological competence. However, the monitoring of immunological function is usually estimated indirectly, on the basis of total or subpopulations of blood cell counts or on the basis of in vitro studies (29) . When estimated in vivo, expression of specific markers or secreted products such as cytokines may help in the determination of cell activation, but no direct assessment of metabolic activity is performed. Recently, Garlick's group [Park et al. (25) ] developed a new approach using the flooding dose method for the in vivo determination of protein synthesis in lymphocytes. This approach is very convenient and has been applied to the study of metabolic changes associated with various situations (5, 13, (17) (18) (19) . However, some problems still need to be solved, such as the possibility to simultaneously measure metabolic activity in different immune cell populations during a period of time sufficient to measure the impact of any specific agent and to reduce the amount of blood required for the calculation of protein synthesis. Indeed, it is particularly relevant to analyze short-term changes induced by nutrients or hormones in these immune cells, i.e., after a few hours of exposure such as a meal intake, to assess their metabolic adaptation and to what extent their functions might be modified. For example, many recent works have emphasized the immunomodulatory action of specific amino acids, i.e., arginine or glutamine, or other compounds such as polyunsaturated fatty acids on immunological functions (4, 7, 8, 10) . Thus this new isotopic approach should be useful to directly assess the metabolic changes of immune functions in these cells in various circumstances. In the present study, we chose to isolate subpopulations of cells devoted to quite specific [peripheral blood mononuclear cells (PBMC)] and nonspecific immunity [polymorphonuclear neutrophils (PMN)] and to measure their metabolic activity on the basis of their protein synthesis rate in a small blood sample by using a primed continuous infusion of the stable, isotopically labeled amino acid [ 13 C]leucine.
MATERIALS AND METHODS
Subjects. Thirteen healthy young adult volunteers participated in the study. Each volunteer had a normal physical examination and blood biochemistry analysis. In particular, we ensured that none of the subjects had relevant acute or chronic disease and that none were taking drugs that might affect the immune system.
The purpose and the potential risks of the study were fully explained, and written informed consent was obtained from each participant. The experimental protocol was approved by the Ethics Committee of the Auvergne region.
Materials. L-[1-13 C]leucine (99 molar percent excess) was obtained from Cambridge Isotope Laboratories (Andover, MA). The isotopic and chemical purities of leucine were checked by gas chromatography-mass spectrometry (GC-MS; Hewlett-Packard 5971A; HewlettPackard, Palo Alto, CA). Solutions of tracers were tested for sterility and pyrogenicity before use and were prepared in sterile apyrogenic water. Throughout each experiment, tracers were membrane-filtered through 0.22-m-pore-size filters.
Experimental protocol. Data were collected in the postabsorptive state after a 10-h overnight fast. On the day of the experiment, two venous tracts were laid on the subject's arms. A catheter was retrogradely inserted into a dorsal vein of the left arm and used for blood sampling. The subject's hand was introduced into a ventilated box heated to 60°C to obtain arterialized blood. Another catheter was inserted into the contralateral arm and used for tracer. After a primed dose of [ 13 In a first study performed in eight subjects, blood samples were taken before any infusion (Ϫ20 and 0 min) and at 120 and 180 min after infusion. Blood was collected into EDTA-containing tubes for plasma isotopic enrichments and for measurement of PBMC and PMN protein synthesis rates after cell isolation.
In a second study, blood samples from five subjects were removed before any infusion (Ϫ20 and 0 min) and at 120, 180, and 240 min after infusion. Blood was collected to evaluate the intracellular free [ 13 C]leucine enrichment and to test the linearity of the incorporation rate of the tracer into PBMC and PMN proteins.
White blood cell isolation. Six milliliters of whole blood were collected in EDTA-treated tubes. Cycloheximide (0.5 mM; Sigma, Saint-Quentin-Fallavier, France) was rapidly added to the fresh blood to prevent further leucine incorporation during cell separation. Leukocytes were isolated by density gradient centrifugation, as previously described (29) . Briefly, whole blood was carefully layered onto a double-discontinuous Ficoll-Hypaque density gradient (Histopaque 1077 and 1119; Sigma) with equal volumes and spun at 700 g for 30 min at room temperature. After centrifugation, the Ficoll-Hypaque layers were aspirated, and PBMC and PMN were collected on the corresponding layers at densities ranging from 1.024 to 1.077 g/ml and 1.077 to 1.119 g/ml, respectively. PBMC and PMN were washed twice with phosphate-buffered saline (PBS; pH 7.4, 150 mM), centrifuged, and resuspended in 1 ml of PBS. Cells were then tested for purity (Ͼ95%) and viability (Ͼ95%) by using May-GrunwaldGiemsa staining and the trypan blue dye exclusion test, respectively. PMN and lymphocyte suspensions were counted in a Malassez chamber, and their proteins were then precipitated in TCA stored at Ϫ80°C before analysis.
Analytical methods. In the first study, plasma [ 13 C]leucine and ␣-[
13 C]ketoisocaproate (KIC) enrichments and concentrations were measured by GC-MS as previously described (1) and were used as precursor pool enrichments to calculate the fractional rate of protein synthesis (FSR). In the second study, we used isotopic enrichment of intracellular free L-[
13 C]leucine as precursor pool enrichment, which was determined from the 6-ml blood samples. After cell isolation and lysis by four freezing-defrosting cycles, intracellular amino acids were extracted by cation exchange chromatography (Dowex 50W 8X; Bio-Rad Laboratories, Hercules, CA), eluted in 4 M NH 4OH, dried down in a SpeedVac (Savant Instruments), and analyzed with a gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS) system (Isochrom; Micromass, Manchester, UK) as their N-acetyl-propyl derivatives. Intracellular protein enrichments were measured after intracellular protein hydrolysis by using GC-C-IRMS with the use of N-acetyl-propyl derivatization.
Calculations. In the first study, leucine kinetics were calculated according to the reciprocal pool model by using plasma leucine or KIC concentrations as an indicator of intracellular leucine enrichment. 
Statistical analysis. Statistical comparison of rates of protein synthesis between PBMC and PMN was made using the unpaired Student's t-test. The achievement of steady state was verified using the repeated-measures ANOVA test. The data are expressed as means Ϯ SE, and differences were taken to be statistically significant if the P value was Ͻ0.05.
RESULTS
First study. In healthy young adult subjects, the PBMC FSR varied between 1.66 and 5.53%/day with a median of 4.02%/ day. The PMN FSR ranged between 1.21 and 1.86%/day with a median of 1.39%/day. The PBMC and PMN FSR were not significantly affected by the plasma precursor pool used, i.e., plasma [ 13 C]leucine or [ 13 C]KIC (P ϭ NS). In addition, the mean PBMC FSR was significantly higher compared with that of the PMN subpopulation (P Ͻ 0.05; see Table 1 ). We also noticed a close inverse relationship between the white blood cell FSR and the total cell count depending on whether the cell count was expressed as a percentage of total leukocyte number (r 2 ϭ 0.62) or as giga per liter (r 2 ϭ 0.57). Second study. Enrichment of the plasma and intracellular free [
13 C]leucine pools did not vary among the three time points studied, i.e., 120, 180, and 240 min (Fig. 1) , showing (Figs. 2 and 3) . Based on the intracellular enrichment in the cells studied, the PBMC protein FSR ranged between 3.33 and 8.60%/day, i.e., 1.54 times higher than the FSR calculated using the [ 13 C]leucine plasma precursor pool (see Table 2 ). The PMN protein FSR varied between 2.26 and 4.04%/day, which was 1.74 higher than the FSR calculated using the plasma enrichment ( Table 2) . As in the first study, the PBMC protein FSR was significantly higher compared with that of the PMN subpopulation (Table 2 ; P Ͻ 0.05).
DISCUSSION
Protection of individuals from microbial, viral, and parasitic invaders is the primary function of the immune system. The immune cells recognize these entities and discriminate them very efficiently and in a specific manner. The final action of this system is to destroy the invading foreign agent. Many in vitro reports have shown that lymphocyte and PMN functions are altered in physiopathological situations, such as growth and aging in various nutritional circumstances, injury, or disease. However, immune cell activation and proliferation result in a wide range of biological effects and production of various proteins that are difficult to establish and monitor in vivo. In addition, a large number of factors can affect protein synthesis and then alter protein synthesis-dependent immune functions, such as cytokine production. Therefore, in vivo protein synthesis determination can be a sensitive and dynamic indicator of cell function disorders and can contribute to our understanding of the link between immune function and metabolism. Such an interaction is bidirectional: the immune system is dependent on substrate availability for its functioning, and conversely, an altered immune response makes a major contribution to the metabolic disturbances seen in infective states. In the present study, we evaluated for the first time the in vivo protein synthesis rate simultaneously in PBMC and PMN from the same blood sample by using the labeled amino acid continuous infusion method. This technique already has been applied for years to the measurement of protein synthesis in numerous tissues such as muscle, liver, and mucosa (for review, see Refs. 15 and 26).
Park et al. (25) previously measured the in vivo protein turnover of lymphocytes from healthy male subjects by using the flooding dose procedure. The advantage of this method is that the assessment of precursor enrichment is facilitated (14, 15) . Ideally, the measurement of precursor enrichment should be made on the aminoacyl-tRNA of the tissue. Nevertheless, because of the extremely small size, rapid turnover, and instability of this pool, this would be impracticably difficult and quite infeasible.
To the best of our knowledge, the present report represents the first documented use of the continuous intravenous infusion method of labeled amino acid to determine the protein synthesis of immune cell preparation. In this technique, the tracer is given by constant infusion at a rate sufficient to achieve, at steady state, a labeling in the plasma pool of 5-10% of the total free amino acid pool. Intracellular amino acid enrichments also did not change over time, ranging from 3 to 5% of the total free intracellular amino acid pool. These observations demonstrated that a steady state was actually reached in the intracellular pool. There is evidence in tissues such as muscle (26) that the Fig. 3 . Linearity of PMN protein isotopic enrichment over time. Data are presented as means Ϯ SE; n ϭ 5 subjects. Enrichment is expressed as %APE. Fig. 1 . Plasma and intracellular free amino acid pool enrichments over time. Data are presented as means Ϯ SE; n ϭ 5 subjects. Enrichment is expressed as atom percent excess (%APE). Repeated-measures ANOVA was performed to test the linearity of plasma and intracellular pool enrichments over time (no significant differences among 120-, 180-, and 240-min time points). PBMC, peripheral blood mononuclear cells; PMN, polymorphonuclear neutrophils. Fig. 2 . Linearity of PBMC protein isotopic enrichment over time. Data are presented as means Ϯ SE; n ϭ 5 subjects. Enrichment is expressed as %APE.
labeling of KIC, a metabolite generated intracellularly from leucine, after tracer infusion is an accurate reflection of the intracellular tRNA pool (22, 26, 31) . However, as demonstrated in this study, enrichment of the free amino acid pool in other tissues may be lower than in the plasma by an amount that varies with the metabolic activity of the tissue considered. This observation led, in our experiment, to an underestimation of protein FSR with the use of the plasma labeled amino acid enrichment. Protein synthesis rate as calculated from intracellular enrichment was 50% higher with a large variation among subjects corresponding to an increase from 35 to 80% compared with that calculated from plasma enrichment. Still, should the technique, in the future, be applied in pathological situations, amino acid concentration will change, as will enrichments in intracellular amino acids pools. This observation will require more rigorous validation in such situations.
Interestingly, the labeled amino acid can be infused as a tracer with little or no effect on the overall metabolism of the cells. With the flooding dose, the exposure of the subjects to a novel stimulus, i.e., a loading dose of amino acids, could induce an activation of immune cells and cause an artifactually greater availability of tracer amino acid to the tRNA synthetase than that which occurred before the application of the flood (8, 26) . The potential disadvantage is the possibility that the change in amino acid concentration might alter directly or indirectly the rate of protein synthesis in the tissue under study. This latter phenomenon may explain the higher values that were observed by others (25) concerning the rate of protein synthesis measured in immune cells by the leucine flooding dose technique (9%/day for lymphocytes) compared with the infusion procedure (6.04 and 2.98%/day for PBMC and PMN, respectively). More recently, the users of the flooding dose method have turned to the use of [ 2 H 5 ]phenylalanine as the flooding amino acid (14) . However, this research group subsequently produced the same data for protein FSR in healthy immune cells as previously described with leucine (5, 12, 13, (17) (18) (19) 23 ). Other authors working with different tissues also reported that the values obtained with the flooding dose protocol appear to be higher than those obtained with a constant infusion technique. The differences described in the literature may be partly explained by the stimulating effect of a flooding dose of amino acids, such as leucine, on protein synthesis but also may be related to the different precursor pool used to calculate protein turnover in these two procedures. Another explanation is that the immune cells export a large part of protein synthesized. Thus the flooding dose is performed during the period when the newly synthesized export proteins remain in the cell, where they contribute appropriately to the estimation of synthesis rate. This later observation means that the flooding dose procedure may reflect the synthesis rate of immune exported proteins, whereas the continuous infusion method may evaluate the constitutive protein pool turnover of this tissue. Ideally, the contribution of exported proteins should have been estimated during the continuous tracer infusion procedure by measuring the synthesis rate of specific proteins, such as immunoglobulins, from plasma samples. It is interesting to note that the FSR of immunoglobulins is higher than the FSR of constitutive proteins (9) .
Blood requirements for isolating PBMC and PMN by density gradient centrifugation and measuring [
13 C]leucine enrichment by mass spectrometry can be reduced to 6 ml per sample with our study method (instead of 20 -60 ml in flooding dose studies), an acceptable blood removal for kinetic studies even in frail populations such as patients, the elderly, or neonates. This new method should be useful to assess in vivo the immune modifications during long-term immunomodulating treatments or pathological situations. In addition, the technique of cell isolation used in this study allows assessment of protein synthesis rate in all white blood cell subsets, i.e., PBMC and PMN, from the same blood sample. From these determinations, it appears that protein synthesis rate is higher in the PBMC subpopulation compared with the neutrophil fraction in healthy young adult subjects. A recent study (19) measured the in vivo protein turnover in lymphocytes and total leukocytes (i.e., 29% lymphocytes, 8% monocytes, 61% PMN, and a negligible count of eosinophils and basophils) from the same healthy volunteers. In this latter work, the in vivo protein synthesis was 67% higher in lymphocytes (9%/day) than in total white blood cells (3.2%/day), confirming the lower FSR in the PMN population, which represents Ͼ60% of the total leukocytes (19) . Taken together, these observations suggest large differences in synthetic activities and functions of immune cells of healthy subjects, with a lower metabolic rate in PMN. This probably reflects the fact that, first, PMN are not active in the absence of stimulation, and second, all activated PMN left the blood compartment to synthesize immunoregulatory factors in tissues. Papet et al. (24) previously presented, in the rat model, the first quantification of protein synthesis in circulating lymphocytes and primary lymphoid tissues. In healthy, well-nourished rats, the protein synthesis rate decreased progressively in bone marrow, which is composed of stem cells, then in thymus, which is the site of maturation, followed by the circulating mature cells. This is consistent with their replicative and metabolic activities. Finally, the protein synthesis rate that we measured in human PBMC was lower than in rat as already Values are means Ϯ SE; n ϭ 5 subjects. FSR is expressed as a percentage of proteins newly synthesized per day. *P Ͻ 0.05 vs. PMN.
described for muscle and intestine proteins and for albumin (1, 2, 3, 6, 21, 27, 28) .
In conclusion, we have set up a new method allowing the determination of the rate of labeled amino acid incorporation into immune cell proteins by using a simple continuous infusion technique. The determination of the protein FSR in mononuclear and neutrophil subpopulations is possible at the same time and from the same sample with this procedure. However, the choice of the free labeled amino acid precursor pool seems to be mandatory because the absolute FSR values obtained by using the plasma tracer enrichment underestimated the FSR of PBMC and PMN. In addition, intracellular amino acid concentration may change depending on the pathological situation with or without any modification of the plasma amino acid profile. Therefore, intracellular pools have to be taken into consideration to calculate white blood cell FSR. Additional effort directed at purification of individual immune proteins for synthesis rate analysis is also warranted. Focusing on the specific proteins within immune system is likely to reveal additional differences in physiopathological situations.
